SWHR Praises Equal but not the same: a male bias reigns in medical research Commentary
SWHR commends Peter Rogers, Professor of Women’s Health Research, Department of Obstetrics and Gynecology, and Director of Research, Royal Women’s…
SWHR Statement in Appreciation for Commissioner Hamburg’s Service
Washington, DC, February 5, 2015 – The Society for Women’s Health Research (SWHR) would like to commend the outgoing Food…
SWHR Statement on President’s Budget and Precision Medicine Initiative
Today, President Barack Obama unveiled his budget request to Congress for the 2016 fiscal year, which provides for critical investment…
DeLauro NIH Funding Bill Will Provide Critically Needed Investments in Medical Research
Statement from Phyllis Greenberger, President and CEO of the Society for Women’s Health Research “On behalf of the Society for…
SWHR Submits comments to FDA Regarding Drug Trials Snapshots
The U.S. Food and Drug Administration (FDA) recently created Drug Trials Snapshots, a new website to give patients, providers, and caregivers information on the…
FDA Issues Final Rule on Pregnancy and Lactation Labeling
The Food and Drug Administration announced a final rule today that sets new standards for labeling information for prescription drugs…
SWHR Salutes the FDA Office of Women’s Health on 20 Years of Advancing Women’s Health
The Society for Women’s Health Research (SWHR®) congratulates the Food and Drug Administration’s (FDA) Office of Women’s Health for 20…
OSSD Offers Recommendations to Basic Scientists on New NIH Research Policies
SWHR would like to congratulate several leading members of the Organization for the Study of Sex Differences (OSSD) on the…
SWHR Applauds NIH-funded Research on Gender Bias in Pre-clinical and Clinical Studies
The National Institutes of Health (NIH) announced that it will invest $10.1 million in supplemental funding to support the research…